Editing Diabetes (TRPM7)

{{tp|p=36717580|t=2023. Adipose-specific deletion of the cation channel TRPM7 inhibits TAK1 kinase-dependent inflammation and obesity in male mice.|pdf=|usr=}}{{36717580}}
{{tp|p=36574297|t=2023. TRPM7 kinase is required for insulin production and compensatory islet responses during obesity.|pdf=|usr=}}{{36574297}}
{{tp|p=34865947|t=2022. Associations between gene expression of magnesium transporters and glucose metabolism in pregnancy.|pdf=|usr=}}{{34865947}}
{{tp|p=34345920|t=2021. TRPM7 is a crucial regulator of pancreatic endocrine development and high-fat-diet-induced beta-cell proliferation.|pdf=|usr=}}{{34345920}}
{{tp|p=34072724|t=2021. The Combined Influence of Magnesium and Insulin on Central Metabolic Functions and Expression of Genes Involved in Magnesium Homeostasis of Cultured Bovine Adipocytes.|pdf=|usr=}}{{34072724}}
{{tp|p=33891828|t=2021. Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells.|pdf=|usr=}}{{33891828}}
{{tp|p=37837806|t=2023. Improvement of actin dynamics and cognitive impairment in diabetes through troxerutin-mediated downregulation of TRPM7/CaN/cofilin.|pdf=|usr=}}{{37837806}}
{{tp|p=31697634|t=2019. Leptin Activates Trpm7 Channels in the Carotid Body As a Mechanism of Obesity-Related Hypertension.|pdf=|usr=}}{{31697634}}
{{tp|p=27574117|t=2016. Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA hybrids.|pdf=|usr=}}{{27574117}}
{{tp|p=24057349|t=2014. Functional TRPV and TRPM channels in human preadipocytes.|pdf=|usr=}}{{24057349}}
{{tp|p=23765921|t=2014. TRPM7 channels regulate proliferation and adipogenesis in 3T3-L1 preadipocytes.|pdf=|usr=}}{{23765921}}
{{tp|p=20875900|t=2010. Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study.|pdf=|usr=}}{{20875900}}
{{tp|p=19098369|t=2008. The role of transient receptor potential channels in metabolic syndrome.|pdf=|usr=}}{{19098369}}
{{tp|p=30742025|t=2019. Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.|pdf=|usr=}}{{30742025}}
{{tp|p=34331987|t=2021. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.|pdf=|usr=}}{{34331987}}
{{tp|p=32393384|t=2020. Effect of long-term treatment of Carvacrol on glucose metabolism in Streptozotocin-induced diabetic mice.|pdf=|usr=}}{{32393384}}
{{tp|p=31604444|t=2019. Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation.|pdf=|usr=}}{{31604444}}
{{tp|p=38186879|t=2024. Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms.|pdf=|usr=}}{{38186879}}
{{ttp|p=36741996|t=2022. Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials.|pdf=|usr=}}{{36741996}}
{{tp|p=36346820|t=2023. Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes.|pdf=|usr=}}{{36346820}}
{{tp|p=35445032|t=2022. Dysregulated Erythroid Mg(2+) Efflux in Type 2 Diabetes.|pdf=|usr=}}{{35445032}}
{{tp|p=34277971|t=2021. Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.|pdf=|usr=}}{{34277971}}
{{tp|p=33866775|t=2021. Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus.|pdf=|usr=}}{{33866775}}
{{tp|p=33747462|t=2021. Association of dietary calcium, magnesium, and vitamin D with type 2 diabetes among US adults: National health and nutrition examination survey 2007-2014-A cross-sectional study.|pdf=|usr=}}{{33747462}}
{{tp|p=31196609|t=2019. Ion channels and transporters in diabetic kidney disease.|pdf=|usr=}}{{31196609}}
{{tp|p=28224192|t=2017. Serum magnesium and the risk of prediabetes: a population-based cohort study.|pdf=|usr=}}{{28224192}}
{{tp|p=28197834|t=2017. Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.|pdf=|usr=}}{{28197834}}
{{tp|p=33716794|t=2021. Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels.|pdf=|usr=}}{{33716794}}
{{tp|p=31572181|t=2019. Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K/AKT/GLUT4 Pathway in Diabetic Mice.|pdf=|usr=}}{{31572181}}
{{tp|p=30889804|t=2019. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling.|pdf=|usr=}}{{30889804}}
{{tp|p=28508457|t=2017. Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.|pdf=|usr=}}{{28508457}}
{{tp|p=37441489|t=2023. Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease.|pdf=|usr=}}{{37441489}}
{{tp|p=36837924|t=2023. Hypomagnesemia as a Risk Factor and Accelerator for Vascular Aging in Diabetes Mellitus and Chronic Kidney Disease.|pdf=|usr=}}{{36837924}}
{{tp|p=36185705|t=2022. Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases.|pdf=|usr=}}{{36185705}}
{{tp|p=35565682|t=2022. The Role of Magnesium in the Pathogenesis of Metabolic Disorders.|pdf=|usr=}}{{35565682}}
{{tp|p=35277073|t=2022. Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome.|pdf=|usr=}}{{35277073}}
{{tp|p=34836340|t=2021. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome.|pdf=|usr=}}{{34836340}}
{{tp|p=31446746|t=2019. Transient Receptor Potential Channels and Metabolism.|pdf=|usr=}}{{31446746}}
{{tp|p=25733456|t=2015. Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women.|pdf=|usr=}}{{25733456}}
{{tp|p=23343670|t=2013. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies.|pdf=|usr=}}{{23343670}}
{{tp|p=33499378|t=2021. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.|pdf=|usr=}}{{33499378}}
{{tp|p=33447354|t=2020. Hypomagnesemia in persons with type 1 diabetes: associations with clinical parameters and oxidative stress.|pdf=|usr=}}{{33447354}}
{{tp|p=33396318|t=2020. Low Dietary Magnesium and Overweight/Obesity in a Mediterranean Population: A Detrimental Synergy for the Development of Hypertension. The SUN Project.|pdf=|usr=}}{{33396318}}
{{tp|p=30742025|t=2019. Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.|pdf=|usr=}}{{30742025}}
{{tp|p=24322525|t=2013. Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge.|pdf=|usr=}}{{24322525}}
{{tp|p=37908255|t=2023. Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors.|pdf=|usr=}}{{37908255}}
{{tp|p=36684386|t=2023. Association of vitamin D and magnesium with insulin sensitivity and their influence on glycemic control.|pdf=|usr=}}{{36684386}}
{{tp|p=31768494|t=2019. Mineral and Electrolyte Disorders With SGLT2i Therapy.|pdf=|usr=}}{{31768494}}
{{ttp|p=30717286|t=2019. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study.|pdf=|usr=}}{{30717286}}
{{tp|p=26265998|t=2015. Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.|pdf=|usr=}}{{26265998}}
{{tp|p=24936262|t=2014. Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.|pdf=|usr=}}{{24936262}}
{{tp|p=33716794|t=2021. Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels.|pdf=|usr=}}{{33716794}}
{{ttp|p=30717286|t=2019. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study.|pdf=|usr=}}{{30717286}}
{{tp|p=37121975|t=2023. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation.|pdf=|usr=}}{{37121975}}
{{tp|p=36147580|t=2022. Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.|pdf=|usr=}}{{36147580}}
{{tp|p=35073578|t=2022. Sulfated Progesterone Metabolites That Enhance Insulin Secretion via TRPM3 Are Reduced in Serum From Women With Gestational Diabetes Mellitus.|pdf=|usr=}}{{35073578}}
{{tp|p=34814650|t=2021. Ion channels alterations in the forebrain of high-fat diet fed rats.|pdf=|usr=}}{{34814650}}
{{tp|p=34554282|t=2022. IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes.|pdf=|usr=}}{{34554282}}
{{tp|p=34402473|t=2021. Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression.|pdf=|usr=}}{{34402473}}
{{tp|p=35733856|t=2022. Circ_0004951 Promotes Pyroptosis of Renal Tubular Cells via the NLRP3 Inflammasome in Diabetic Kidney Disease.|pdf=|usr=}}{{35733856}}
{{tp|p=33679451|t=2021. Cardiovascular and Metabolic Crosstalk in the Brain: Leptin and Resistin.|pdf=|usr=}}{{33679451}}
{{tp|p=30524286|t=2018. Gastrodin Ameliorates Cognitive Dysfunction in Diabetes Rat Model via the Suppression of Endoplasmic Reticulum Stress and NLRP3 Inflammasome Activation.|pdf=|usr=}}{{30524286}}
{{tp|p=28217522|t=2017. A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus.|pdf=|usr=}}{{28217522}}
{{tp|p=35967128|t=2022. Expression of Transient Receptor Potential Channel Genes and Their Isoforms in Alpha-Cells and Beta-Cells of Human Islets of Langerhans.|pdf=|usr=}}{{35967128}}
{{tp|p=33729996|t=2021. Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction.|pdf=|usr=}}{{33729996}}
{{tp|p=33374507|t=2020. The Importance of Non-Coding RNAs in Neurodegenerative Processes of Diabetes-Related Molecular Pathways.|pdf=|usr=}}{{33374507}}
{{tp|p=32439805|t=2020. The magnesium transporter NIPAL1 is a pancreatic islet-expressed protein that conditionally impacts insulin secretion.|pdf=|usr=}}{{32439805}}
{{tp|p=31974165|t=2020. Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation.|pdf=|usr=}}{{31974165}}
{{tp|p=28811850|t=2017. Effect of Sodium Glucose Cotransporter 2 Inhibitors With Low SGLT2/SGLT1 Selectivity on Circulating Glucagon-Like Peptide 1 Levels in Type 2 Diabetes Mellitus.|pdf=|usr=}}{{28811850}}
{{tp|p=28630088|t=2017. The islet-resident macrophage is in an inflammatory state and senses microbial products in blood.|pdf=|usr=}}{{28630088}}
{{tp|p=37790634|t=2023. Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice.|pdf=|usr=}}{{37790634}}
{{tp|p=36571340|t=2023. Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface.|pdf=|usr=}}{{36571340}}
{{tp|p=34836963|t=2021. CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease.|pdf=|usr=}}{{34836963}}
{{tp|p=28436964|t=2017. SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.|pdf=|usr=}}{{28436964}}
{{tp|p=35778900|t=2022. Leptin-mediated neural targets in obesity hypoventilation syndrome.|pdf=|usr=}}{{35778900}}
{{tp|p=33854178|t=2021. SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways.|pdf=|usr=}}
{{ttp|p=33544938|t=2021. Metabolic sensor O-GlcNAcylation regulates megakaryopoiesis and thrombopoiesis through c-Myc stabilization and integrin perturbation.|pdf=|usr=}}{{33544938}}
{{tp|p=37988198|t=2023. Investigating EGF and PAG1 as necroptosis-related biomarkers for diabetic nephropathy: an in silico and in vitro validation study.|pdf=|usr=}}{{37988198}}
{{tp|p=34927008|t=2021. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?|pdf=|usr=}}{{34927008}}
{{tp|p=33402547|t=2021. The near-infrared dye IR-61 restores erectile function in a streptozotocin-induced diabetes model via mitochondrial protection.|pdf=|usr=}}{{33402547}}
{{tp|p=38118414|t=2023. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.|pdf=|usr=}}{{38118414}}
{{tp|p=21171985|t=2010. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients.|pdf=|usr=}}{{21171985}}
{{tp|p=33195411|t=2020. A Transcriptomic Analysis Reveals Novel Patterns of Gene Expression During 3T3-L1 Adipocyte Differentiation.|pdf=|usr=}}{{33195411}}
{{tp|p=32168890|t=2020. Molecular Regulations and Functions of the Transient Receptor Potential Channels of the Islets of Langerhans and Insulinoma Cells.|pdf=|usr=}}{{32168890}}
{{tp|p=32162606|t=2019. Reactive oxygen species are implicated in altering magnesium homeostasis in endothelial cells exposed to high glucose.|pdf=|usr=}}{{32162606}}
{{tp|p=31650715|t=2019. Functional expression of TRPM7 as a Ca(2+) influx pathway in adipocytes.|pdf=|usr=}}{{31650715}}
{{tp|p=31163064|t=2019. Low extracellular magnesium does not impair glucose-stimulated insulin secretion.|pdf=|usr=}}{{31163064}}
{{tp|p=37282948|t=2023. [Lianmei Qiwu Decoction relieves diabetic cardiac autonomic neuropathy by regulating AMPK/TrkA/TRPM7 signaling pathway].|pdf=|usr=}}{{37282948}}
{{tp|p=31180948|t=2019. Magnesium-responsive genes are downregulated in diabetic patients after a three-month exercise program on a bicycle ergometer.|pdf=|usr=}}{{31180948}}
{{tp|p=27464700|t=2017. Expression of Transient Receptor Potential Channels in the Purified Human Pancreatic beta-Cells.|pdf=|usr=}}{{27464700}}
{{tp|p=36421426|t=2022. Citronellal Attenuates Oxidative Stress-Induced Mitochondrial Damage through TRPM2/NHE1 Pathway and Effectively Inhibits Endothelial Dysfunction in Type 2 Diabetes Mellitus.|pdf=|usr=}}{{36421426}}
{{tp|p=35656112|t=2022. DR1 Activation Inhibits the Proliferation of Vascular Smooth Muscle Cells through Increasing Endogenous H(2)S in Diabetes.|pdf=|usr=}}{{35656112}}
{{tp|p=34944530|t=2021. Insulin-Responsive Transcription Factors.|pdf=|usr=}}{{34944530}}
{{tp|p=34631209|t=2021. Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.|pdf=|usr=}}{{34631209}}
{{tp|p=34452694|t=2021. The new kids on the block: Emerging obesogens.|pdf=|usr=}}{{34452694}}
{{tp|p=34359828|t=2021. The Role of cAMP in Beta Cell Stimulus-Secretion and Intercellular Coupling.|pdf=|usr=}}{{34359828}}
{{tp|p=34180254|t=2022. Contribution of Mitochondria to Insulin Secretion by Various Secretagogues.|pdf=|usr=}}{{34180254}}
{{tp|p=33672062|t=2021. Lipotoxic Impairment of Mitochondrial Function in beta-Cells: A Review.|pdf=|usr=}}{{33672062}}
{{tp|p=33572903|t=2021. The Pancreatic beta-Cell: The Perfect Redox System.|pdf=|usr=}}{{33572903}}
{{tp|p=23651844|t=2013. Enhanced insulin clearance in mice lacking TRPM8 channels.|pdf=|usr=}}{{23651844}}
{{tp|p=22275755|t=2012. TRPM2 Ca2+ channel regulates energy balance and glucose metabolism.|pdf=|usr=}}{{22275755}}
{{tp|p=37731140|t=2023. Secondary diabetes mellitus in pheochromocytomas and paragangliomas.|pdf=|usr=}}{{37731140}}
{{tp|p=36589805|t=2022. Mechanistic investigations of diabetic ocular surface diseases.|pdf=|usr=}}{{36589805}}
{{tp|p=36467075|t=2022. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis.|pdf=|usr=}}{{36467075}}
{{tp|p=36239048|t=2022. Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity.|pdf=|usr=}}{{36239048}}
{{tp|p=36057030|t=2022. Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial.|pdf=|usr=}}{{36057030}}
{{tp|p=35872985|t=2022. The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture.|pdf=|usr=}}{{35872985}}
{{tp|p=35387335|t=2022. Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis.|pdf=|usr=}}{{35387335}}
{{tp|p=35069450|t=2021. Liraglutide Activates Type 2 Deiodinase and Enhances beta3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue.|pdf=|usr=}}{{35069450}}
{{tp|p=34636409|t=2021. Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion.|pdf=|usr=}}{{34636409}}
{{tp|p=33150398|t=2021. Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.|pdf=|usr=}}{{33150398}}
{{tp|p=32848741|t=2020. Ionic Channels as Potential Therapeutic Targets for Erectile Dysfunction: A Review.|pdf=|usr=}}{{32848741}}
{{tp|p=32280378|t=2020. Melatonin: new insights on its therapeutic properties in diabetic complications.|pdf=|usr=}}{{32280378}}
{{tp|p=31231424|t=2019. Genetic and Epigenetic Studies in Diabetic Kidney Disease.|pdf=|usr=}}{{31231424}}
{{tp|p=30364192|t=2018. Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1.|pdf=|usr=}}{{30364192}}
{{tp|p=29201240|t=2017. Glucagon-like peptide-1 potentiates glucose-stimulated insulin secretion via the transient receptor potential melastatin 2 channel.|pdf=|usr=}}{{29201240}}
{{tp|p=23734095|t=2013. Ion channels in the central regulation of energy and glucose homeostasis.|pdf=|usr=}}{{23734095}}
{{tp|p=36453164|t=2023. Current understanding of imeglimin action on pancreatic beta-cells: Involvement of mitochondria and endoplasmic reticulum homeostasis.|pdf=|usr=}}{{36453164}}
{{tp|p=34523242|t=2022. A novel mechanism of imeglimin-mediated insulin secretion via the cADPR-TRP channel pathway.|pdf=|usr=}}{{34523242}}
{{tp|p=32129549|t=2020. Transient receptor potential vanilloid 4 channels as therapeutic targets in diabetes and diabetes-related complications.|pdf=|usr=}}{{32129549}}
{{tp|p=31998809|t=2020. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.|pdf=|usr=}}{{31998809}}
{{tp|p=30125956|t=2019. Pulmonary vascular dysfunction in metabolic syndrome.|pdf=|usr=}}{{30125956}}
{{tp|p=30613832|t=2017. Role of Transient Receptor Potential Channels Trpv1 and Trpm8 in Diabetic Peripheral Neuropathy.|pdf=|usr=}}{{30613832}}
{{tp|p=36984867|t=2023. Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease.|pdf=|usr=}}{{36984867}}
{{tp|p=36966947|t=2023. Neuronal loss of TRPM8 leads to obesity and glucose intolerance in male mice.|pdf=|usr=}}{{36966947}}
{{tp|p=36677809|t=2023. GLP-1R Signaling and Functional Molecules in Incretin Therapy.|pdf=|usr=}}{{36677809}}
{{tp|p=34777695|t=2021. The Mitochondrial-Associated Endoplasmic Reticulum Membrane and Its Role in Diabetic Nephropathy.|pdf=|usr=}}{{34777695}}
{{tp|p=33606763|t=2021. Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells.|pdf=|usr=}}{{33606763}}
{{tp|p=29088850|t=2017. Dietary menthol-induced TRPM8 activation enhances WAT "browning" and ameliorates diet-induced obesity.|pdf=|usr=}}{{29088850}}
{{tp|p=25059284|t=2014. Oxidative stress increases pulmonary vascular permeability in diabetic rats through activation of transient receptor potential melastatin 2 channels.|pdf=|usr=}}{{25059284}}
{{tp|p=34029747|t=2021. Cutaneous innervation in impaired diabetic wound healing.|pdf=|usr=}}{{34029747}}
{{tp|p=32863218|t=2020. Metformin alleviates lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells.|pdf=|usr=}}{{32863218}}
{{tp|p=29707621|t=2018. Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms.|pdf=|usr=}}{{29707621}}
{{tp|p=27649495|t=2016. Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3.|pdf=|usr=}}{{27649495}}